Evidence map›Paper›PMID 32815744›Full record

ReviewBioTechniques2020

PCR past, present and future.

Hanliang Zhu, Haoqing Zhang, Ying Xu, Soňa Laššáková, Marie Korabečná, Pavel Neužil

Abstract readReview
In one paragraph

Review in BioTechniques, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 157 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
157citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

157 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Magneto-responsive piezoelectric CoFeMaterials today. Bio · 2026
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Potential value streams of an integrated Canadian serosurveillance network.Canadian journal of public health = Revue canadienne de sante publique · 2026
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review

97 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hanliang ZhuDepartment of Microsystem Engineering, School of Mechanical Engineering, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, PR China.ORCID 0000-0003-2431-7005
Haoqing ZhangDepartment of Microsystem Engineering, School of Mechanical Engineering, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, PR China.
Ying XuDepartment of Microsystem Engineering, School of Mechanical Engineering, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, PR China.
Soňa LaššákováInstitute of Biology & Medical Genetics, First Faculty of Medicine, Charles University & General University Hospital in Prague, Purkyně Institute, Albertov 4, Praha 2 128 00, Czech Republic.
Marie KorabečnáInstitute of Biology & Medical Genetics, First Faculty of Medicine, Charles University & General University Hospital in Prague, Purkyně Institute, Albertov 4, Praha 2 128 00, Czech Republic.ORCID 0000-0003-2438-817X
Pavel NeužilDepartment of Microsystem Engineering, School of Mechanical Engineering, Northwestern Polytechnical University, Xi'an, Shaanxi 710072, PR China.ORCID 0000-0001-9040-281X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PCR has become one of the most valuable techniques currently used in bioscience, diagnostics and forensic science. Here we review the history of PCR development and the technologies that have evolved from the original PCR method. Currently, there are two main areas of PCR utilization in bioscience: high-throughput PCR systems and microfluidics-based PCR devices for point-of-care (POC) applications. We also discuss the commercialization of these techniques and conclude with a look into their modifications and use in innovative areas of biomedicine. For example, real-time reverse transcription PCR is the gold standard for SARS-CoV-2 diagnoses. It could also be used for POC applications, being a key component of the sample-to-answer system.

Indexed as

AnimalsBetacoronavirusClinical Laboratory TechniquesCoronavirus InfectionsCOVID-19COVID-19 TestingEquipment DesignHumansMicrofluidic Analytical TechniquesPandemicsPneumonia, ViralPoint-of-Care SystemsPolymerase Chain ReactionSARS-CoV-2COVID-19digital PCRmicrofluidicsPCRpoint-of-care diagnosticsportable systemsreverse transcription PCRRNA virus diagnoses

Identifiers

PMID32815744
PMCPMC7439763

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.